Chronic Inflammation in Ulcerative Colitis Causes Long-Term Changes in Goblet Cell Function

[1]  L. Arike,et al.  An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function , 2021, Science.

[2]  D. Rubin,et al.  Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission , 2020, Alimentary pharmacology & therapeutics.

[3]  M. Donowitz,et al.  Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection , 2020, Gut microbes.

[4]  R. Paulssen,et al.  Transcriptional Signatures That Define Ulcerative Colitis in Remission , 2020, Inflammatory bowel diseases.

[5]  J. Yamamoto-Furusho,et al.  ABCC7/CFTR Expression is Down-regulated in Patients with Active Ulcerative Colitis , 2020 .

[6]  N. Akhtar,et al.  Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis , 2019, Gut.

[7]  A. Verkman,et al.  cAMP Stimulates SLC26A3 Activity in Human Colon by a CFTR-Dependent Mechanism That Does Not Require CFTR Activity , 2018, bioRxiv.

[8]  M. Donowitz,et al.  Molecular Basis and Differentiation-Associated Alterations of Anion Secretion in Human Duodenal Enteroid Monolayers , 2018, Cellular and molecular gastroenterology and hepatology.

[9]  M. Donowitz,et al.  A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions , 2017, Scientific Reports.

[10]  P. Jung,et al.  Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis , 2016, Gut.

[11]  C. Serrano,et al.  The pro-inflammatory cytokines IFNγ/TNFα increase chromogranin A-positive neuroendocrine cells in the colonic epithelium. , 2016, The Biochemical journal.

[12]  M. Halushka,et al.  Enterohemorrhagic Escherichia coli Reduces Mucus and Intermicrovillar Bridges in Human Stem Cell-Derived Colonoids , 2015, Cellular and molecular gastroenterology and hepatology.

[13]  W. Xia,et al.  Slc26a3 deficiency is associated with loss of colonic HCO3− secretion, absence of a firm mucus layer and barrier impairment in mice , 2014, Acta physiologica.

[14]  Lilia Zouiten-Mekki,et al.  [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases]. , 2013, Medecine sciences : M/S.

[15]  P. Quinton,et al.  Normal mucus formation requires cAMP‐dependent HCO3− secretion and Ca2+‐mediated mucin exocytosis , 2013, The Journal of physiology.

[16]  C. Abraham,et al.  TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. , 2013, Gastroenterology.

[17]  A. Gewirtz,et al.  Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis , 2013, Gut.

[18]  R. Wollman,et al.  Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion , 2012, Nature Cell Biology.

[19]  M. Parkes,et al.  Mucosal genome‐wide methylation changes in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[20]  I. Ordás,et al.  Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations , 2012, Gut.

[21]  M. Johansson,et al.  Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. , 2012, Glycobiology.

[22]  J. Wehkamp,et al.  Inflammatory bowel disease: an impaired barrier disease , 2012, Langenbeck's Archives of Surgery.

[23]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[24]  P. Quinton,et al.  A new role for bicarbonate in mucus formation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[25]  O. Nielsen,et al.  Genome‐wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis , 2010, Inflammatory bowel diseases.

[26]  Linheng Li,et al.  Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. , 2010, Immunity.

[27]  R. Sidhu,et al.  Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? , 2010, Inflammatory bowel diseases.

[28]  R. Lisle.  Pass the bicarb: the importance of HCO3– for mucin release , 2009 .

[29]  P. Quinton,et al.  Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. , 2009, The Journal of clinical investigation.

[30]  G. Hansson,et al.  A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. , 2009, Glycobiology.

[31]  J. Marth,et al.  Glycosyltransferase Function in Core 2-Type Protein O Glycosylation , 2009, Molecular and Cellular Biology.

[32]  Guoxing Wang,et al.  Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. , 2009, Differentiation; research in biological diversity.

[33]  R. D. De Lisle.  Pass the bicarb: the importance of HCO3- for mucin release. , 2009, The Journal of clinical investigation.

[34]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[35]  L. Abdullah,et al.  Mucin secretion and PKC isoforms in SPOC1 goblet cells: differential activation by purinergic agonist and PMA. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[36]  J. Kere,et al.  Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[37]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[38]  D. Evans,et al.  Three Characteristics Associated with Enterotoxigenic Escherichia coli Isolated from Man , 1973, Infection and immunity.